Are two doses of human papillomavirus vaccine sufficient for girls aged 15–18 years? Results from a cohort study in India

Extending two-dose recommendations of HPV vaccine to girls between 15 and 18 years will reduce program cost and improve compliance. Immunogenicity and vaccine targeted HPV infection outcomes were compared between 1795 girls aged 15–18 years receiving two (1–180 days) and 1515 girls of same age recei...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Papillomavirus Res
Main Authors: Bhatla, Neerja, Nene, Bhagwan M., Joshi, Smita, Esmy, Pulikottil O., Poli, Usha Rani Reddy, Joshi, Geeta, Verma, Yogesh, Zomawia, Eric, Pimple, Sharmila, Prabhu, Priya R., Basu, Partha, Muwonge, Richard, Hingmire, Sanjay, Sauvaget, Catherine, Lucas, Eric, Pawlita, Michael, Gheit, Tarik, Jayant, Kasturi, Malvi, Sylla G., Siddiqi, Maqsood, Michel, Angelika, Butt, Julia, Sankaran, Subha, Kannan, Thiraviam Pillai Rameshwari Ammal, Varghese, Rintu, Divate, Uma, Willhauck-Fleckenstein, Martina, Waterboer, Tim, Müller, Martin, Sehr, Peter, Kriplani, Alka, Mishra, Gauravi, Jadhav, Radhika, Thorat, Ranjit, Tommasino, Massimo, Pillai, M. Radhakrishna, Sankaranarayanan, Rengaswamy
Formato: Artigo
Idioma:Inglês
Publicado em: Elsevier 2018
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6047463/
https://ncbi.nlm.nih.gov/pubmed/29578097
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.pvr.2018.03.008
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados